Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Katz Michael W, Executive. Director active across 1 company, notably Organogenesis Holdings Inc.. Aggregated, 8 disclosures have been logged. Breakdown: 8 buys · 0 sell. Total volume traded: €219k. Activity tracked since 17 August 2021. The latest transaction was filed on 18 November 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Katz Michael W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12,000 shares@ US$13.5563.3% of flowClass A Common StockSEC:0001661181-21-000066:0
Canonical exit: 15 Nov 2021 (T+90)
8 of 8 declarations
About Katz Michael W
KATZ MICHAEL W is an executive at Organogenesis Holdings Inc. (XNAS). Across 8 filings in total, the 8 sampled filings between 2021-08-19 and 2022-11-22 were acquisitions, with total purchases of EUR 219243 and no sales.